World's Best Scientists 2026 revealed!
Olivier Benveniste

Olivier Benveniste

D-Index & Metrics

Immunology

D-Index
70
Citations
16050
World Ranking
2435
National Ranking
100

Overview

Olivier Benveniste is affiliated with Université Paris Cité in France and has contributed extensively to the field of medicine, with a particular focus on inflammatory myopathies and related disorders. Their research spans several subfields including epidemiology, rheumatology, molecular biology, neurology, and dermatology, reflecting a multidisciplinary approach to medical science.

The main topics covered in their work include:

  • Inflammatory Myopathies and Dermatomyositis
  • Eosinophilic Disorders and Syndromes
  • Muscle Physiology and Disorders
  • Skin Diseases and Diabetes
  • Cancer Immunotherapy and Biomarkers
  • COVID-19 Clinical Research Studies
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Benveniste's publication record includes numerous appearances in several notable journals. Frequent publication venues are:

  • La Revue de Médecine Interne
  • Neuromuscular Disorders
  • Lara D. Veeken
  • Annals of the Rheumatic Diseases
  • Autoimmunity Reviews

Recent significant papers authored or coauthored by Benveniste include:

  • Immune-mediated necrotizing myopathy: clinical features and pathogenesis, 2020, Nature Reviews Rheumatology
  • Different phenotypes in dermatomyositis associated with anti-MDA5 antibody, 2020, Neurology
  • Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis, 2023, Cancer Discovery
  • Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities, 2020, Autoimmunity Reviews
  • Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies, 2020, JCI Insight

The researcher frequently collaborates with several individuals, including:

  • Yves Allenbach
  • Sarah Léonard-Louis
  • Werner Stenzel
  • K. Mariampillai
  • A. Rigolet

Benveniste's scholarly contributions are primarily situated within medicine, with 344 publications in total and particular emphasis on epidemiological and rheumatological aspects.

Best Publications

  • Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors.

    Sylvie Boutin;Virginie Monteilhet;Philippe Veron;Christian Leborgne

  • 224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016.

    Yves Allenbach;Andrew L Mammen;Olivier Benveniste;Werner Stenzel

  • Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies

    Kubéraka Mariampillai;Benjamin Granger;Damien Amelin;Marguerite Guiguet

  • Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity.

    Baptiste Hervier;Hervé Devilliers;Raluca Stanciu;Alain Meyer

  • Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer

    Mehdi Touat;Thierry Maisonobe;Samuel Knauss;Omar Ben Hadj Salem

  • Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin.

    Yves Allenbach;Laurent Drouot;Aude Rigolet;Jean Luc Charuel

  • Immune-mediated necrotizing myopathy: clinical features and pathogenesis.

    Yves Allenbach;Olivier Benveniste;Werner Stenzel;Olivier Boyer

  • High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody.

    Yves Allenbach;Jeremy Keraen;Anne-Marie Bouvier;Valérie Jooste

  • Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

    Pierre-Louis Tharaux;Gilles Pialoux;Arthur Pavot;Xavier Mariette

  • Correlation of anti–signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy

    Olivier Benveniste;Laurent Drouot;Fabienne Jouen;Jean-Luc Charuel

  • JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis.

    Leandro Ladislau;Leandro Ladislau;Xavier Suárez-Calvet;Xavier Suárez-Calvet;Ségolène Toquet;Océane Landon-Cardinal

  • Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: Study of 121 cases

    Yves Allenbach;Yurdagul Uzunhan;Ségolène Toquet;Gaëlle Leroux

  • Phase I study of dystrophin plasmid-based gene therapy in Duchenne/Becker muscular dystrophy.

    Norma B. Romero;Serge Braun;Olivier Benveniste

  • A 10 Patient Case Report on the Impact of Plasmapheresis Upon Neutralizing Factors Against Adeno-associated Virus (AAV) Types 1, 2, 6, and 8

    Virginie Monteilhet;Samir Saheb;Sylvie Boutin;Christian Leborgne

  • Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis.

    Benjamin Terrier;Guillaume Geri;Wahiba Chaara;Yves Allenbach

  • Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients

    David Lebeaux;Camille Francès;Stéphane Barete;Bertrand Wechsler

  • Immune Checkpoint Inhibitor-Associated Myositis: Expanding the Spectrum of Cardiac Complications of the Immunotherapy Revolution.

    Céline Anquetil;Joe-Elie Salem;Bénédicte Lebrun-Vignes;Douglas B. Johnson

  • Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups

    Simon Rothwell;Robert G Cooper;Ingrid E Lundberg;Frederick W Miller

  • Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies.

    Louiza Arouche-Delaperche;Yves Allenbach;Damien Amelin;Corinna Preusse

  • Necrosis in anti-SRP+ and anti-HMGCR+myopathies: Role of autoantibodies and complement.

    Yves Allenbach;Louiza Arouche-Delaperche;Corinna Preusse;Helena Radbruch

  • Mechanisms Involved in the Low-Level Regeneration of CD4+ Cells in HIV-1—Infected Patients Receiving Highly Active Antiretroviral Therapy Who Have Prolonged Undetectable Plasma Viral Loads

    Olivier Benveniste;Antoine Flahault;Florence Rollot;Carole Elbim

  • Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis

    Lénaig Mescam-Mancini;Yves Allenbach;Yves Allenbach;Baptiste Hervier;Baptiste Hervier;Hervé Devilliers

Frequent Co-Authors

Lucile Musset
Lucile Musset Sorbonne University
Bruno Eymard
Bruno Eymard Université Paris Cité
Olivier Boyer
Olivier Boyer University of Rouen
Patrice Cacoub
Patrice Cacoub Sorbonne University
David Klatzmann
David Klatzmann Sorbonne University
Eric Hachulla
Eric Hachulla University of Lille
David Saadoun
David Saadoun Université Paris Cité
Ingrid E. Lundberg
Ingrid E. Lundberg Karolinska University Hospital
Michael G. Hanna
Michael G. Hanna University College London
Nathalie Costedoat-Chalumeau
Nathalie Costedoat-Chalumeau Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in studying Immunology, exploring related healthcare degrees online can broaden career opportunities. Nursing programs, in particular, offer diverse paths that complement immunology knowledge.

Many students begin with which lpn programs are easiest to get into, providing a quicker entry into the healthcare field. These programs serve as stepping stones toward more advanced nursing roles.

For non-nurses aiming to change careers, several options exist like online rn programs for non nurses. These programs fast-track the pathway into registered nursing, leveraging prior experience or education from other fields.

To accelerate clinical expertise, students can consider easiest accelerated nursing programs that facilitate quicker BSN completion, allowing earlier entry into immunology-focused clinical roles.

Finally, for nurses ready to take on advanced responsibilities, accelerated rn to np programs prepare candidates for nurse practitioner roles, often specializing in immunology-related care such as infectious diseases or autoimmune conditions.

Exploring these related degrees supports a well-rounded approach to immunology careers, combining scientific understanding with practical healthcare skills.

Best Scientists Citing Olivier Benveniste

Trending Scientists